- Home
- Industry Reports
- Biotechnology
- Healthcare
- Europe Gene Expression Analysis Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Gene Expression is a process where genetic data is used to produce gene products either protein or RNA. The genetic code in DNA helps to study gene expression and its impact on the organism. In the study of genetic, gene expression is the starting stage at which genotype is transformed into phenotype.
Europe Gene Expression Analysis Market Segments Size & Growth:
Gene Expression Analysis Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are by technological developments, increase research in genomics, government funding and healthcare awareness among individuals. However, lack of skilled labour, expensive equipment hinders the growth of the Europe gene expression market.
Europe Gene Expression Analysis Market Segments Share:
Europe Gene Expression Analysis Market is categorised into by technology which consists of next-generation sequencing, microarray, Sanger sequencing, polymerase chain reaction, and others. Next generation has the most significant share as they boost adoption of gene expression is technique. By usage, they are instruments, reagents, and kits. Reagents have the most extensive share as they increase the equipment installations and promoting research funding. The application is segregated into biotechnology, drug discovery, and diagnostic laboratories. Drug discovery is expected to have the most significant share of the market as it helps to study more about genetic disorders and to prevent them.
By Geography, Germany is dominating the gene expression analysis market, and the growth in Europe is mainly attributed because of the increasing well-established healthcare facilities and production of genetically modified crops. Furthermore, UK is witnessing the fastest growth during the forecast period, due to concerns about the health issues, investments in biotechnology and biomedical industries.
Europe Gene Expression Analysis Market Segments Trends:
- In a recent study, change in a gene that encodes the CYP2C19 enzyme makes a high difference in the level of escitalopram in patients.
- In January 2017, Bio-Rad Laboratories, Inc., acquired RainDace Technologies, Inc. to expand its operations.
Europe Gene Expression Analysis Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Oxford Gene Technology, Inc.
- Qiagen N.V
- PerkinElmer
- Novogene Corporation.
- Illumina, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing Genomics database
4.1.2 Technological advancement
4.1.3 Increased government funding
4.2 Restraints
4.2.1 Lack of skilled professional
4.2.2 Expensive instruments
4.3 Opportunities
4.3.1 Increase in health awareness
4.3.2 Demand for Gene Expression in institutions
4.4 Challenges
4.4.1. Patent capitalisation
4.4.2. Expensive equipment.
Chapter 5 Europe Gene Expression Analysis Market – By Technology
5.1 Next Generation Sequencing
5.2 Microarray
5.3 Sanger Sequencing
5.4 Polymerase Chain Reaction
5.5 Others
Chapter 6 Europe Gene Expression Analysis Market – By Usage
6.1 Instruments
6.2 Reagents
6.3 Kits
6.4 Others
Chapter 7 Europe Gene Expression Analysis Market – By Application
7.1 Biotechnology
7.2 Diagnostic Laboratories
7.3 Drug Discovery
7.4 Others
Chapter 8 Europe Gene Expression Analysis Market – By Geography
8.1 Introduction
8.2 Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
Chapter 9 Europe Gene Expression Analysis Market – Company Profiles
9.1. Luminex Corporation
9.2. TAKARA BIO INC.
9.3. Life Technologies
9.4. Bio-Rad Technologies
9.5. Oxford Gene Technology, Inc.
9.6. Qiagen N.V
9.7. PerkinElmer
9.8. Novogene Corporation.
9.9. Illumina, Inc.
9.10. Agilent Technologies
9.11. GE Healthcare
9.12. Promega Corporation
9.13. Roche Diagnostics
9.14. IntegraGen.
9.15. Affymetrix Inc.
Chapter 10 Europe Gene Expression Analysis Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Gene Expression is a process where genetic data is used to produce gene products either protein or RNA. The genetic code in DNA helps to study gene expression and its impact on the organism. In the study of genetic, gene expression is the starting stage at which genotype is transformed into phenotype.
Europe Gene Expression Analysis Market Segments Size & Growth:
Gene Expression Analysis Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are by technological developments, increase research in genomics, government funding and healthcare awareness among individuals. However, lack of skilled labour, expensive equipment hinders the growth of the Europe gene expression market.
Europe Gene Expression Analysis Market Segments Share:
Europe Gene Expression Analysis Market is categorised into by technology which consists of next-generation sequencing, microarray, Sanger sequencing, polymerase chain reaction, and others. Next generation has the most significant share as they boost adoption of gene expression is technique. By usage, they are instruments, reagents, and kits. Reagents have the most extensive share as they increase the equipment installations and promoting research funding. The application is segregated into biotechnology, drug discovery, and diagnostic laboratories. Drug discovery is expected to have the most significant share of the market as it helps to study more about genetic disorders and to prevent them.
By Geography, Germany is dominating the gene expression analysis market, and the growth in Europe is mainly attributed because of the increasing well-established healthcare facilities and production of genetically modified crops. Furthermore, UK is witnessing the fastest growth during the forecast period, due to concerns about the health issues, investments in biotechnology and biomedical industries.
Europe Gene Expression Analysis Market Segments Trends:
- In a recent study, change in a gene that encodes the CYP2C19 enzyme makes a high difference in the level of escitalopram in patients.
- In January 2017, Bio-Rad Laboratories, Inc., acquired RainDace Technologies, Inc. to expand its operations.
Europe Gene Expression Analysis Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Oxford Gene Technology, Inc.
- Qiagen N.V
- PerkinElmer
- Novogene Corporation.
- Illumina, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing Genomics database
4.1.2 Technological advancement
4.1.3 Increased government funding
4.2 Restraints
4.2.1 Lack of skilled professional
4.2.2 Expensive instruments
4.3 Opportunities
4.3.1 Increase in health awareness
4.3.2 Demand for Gene Expression in institutions
4.4 Challenges
4.4.1. Patent capitalisation
4.4.2. Expensive equipment.
Chapter 5 Europe Gene Expression Analysis Market – By Technology
5.1 Next Generation Sequencing
5.2 Microarray
5.3 Sanger Sequencing
5.4 Polymerase Chain Reaction
5.5 Others
Chapter 6 Europe Gene Expression Analysis Market – By Usage
6.1 Instruments
6.2 Reagents
6.3 Kits
6.4 Others
Chapter 7 Europe Gene Expression Analysis Market – By Application
7.1 Biotechnology
7.2 Diagnostic Laboratories
7.3 Drug Discovery
7.4 Others
Chapter 8 Europe Gene Expression Analysis Market – By Geography
8.1 Introduction
8.2 Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
Chapter 9 Europe Gene Expression Analysis Market – Company Profiles
9.1. Luminex Corporation
9.2. TAKARA BIO INC.
9.3. Life Technologies
9.4. Bio-Rad Technologies
9.5. Oxford Gene Technology, Inc.
9.6. Qiagen N.V
9.7. PerkinElmer
9.8. Novogene Corporation.
9.9. Illumina, Inc.
9.10. Agilent Technologies
9.11. GE Healthcare
9.12. Promega Corporation
9.13. Roche Diagnostics
9.14. IntegraGen.
9.15. Affymetrix Inc.
Chapter 10 Europe Gene Expression Analysis Market – Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.